Jan

20

Texas Risperdal Trial Ends When Janssen Settles For $ 158M, Company Says

January 20, 2012 | Leave a Comment

AUSTIN, Texas – Johnson & Johnson subsidiary Janssen LLP said Jan. 19 that it has agreed to pay $ 158 million to settle claims by Texas that it defrauded the Medicaid program through its off-label promotion of the atypical antipsychotic drug Risperdal (State of Texas, ex rel. Allen Jones v. Janssen LP, No. D-1GV-04-001288, Texas [...]

Aug

30

Texas Supreme Court Vacates $ 7.7M Vioxx Verdict; Science Standard Was Unmet

August 30, 2011 | Leave a Comment

AUSTIN, Texas – The Texas Supreme Court on Aug. 26 reversed a $ 7.75 million Vioxx death verdict after ruling that the plaintiff had not met the state’s requirements for scientific reliability to prove that short-term exposure to the prescription pain drug caused a fatal heart attack (Merck & Co., Inc. v. Felicia Garza, et [...]

Jun

29

Texas Panel Affirms Expert Admission, Verdict For Hair Dye Victim

June 29, 2011 | Leave a Comment

CORPUS CHRISTI, Texas – A manicurist does not need to be a licensed cosmetologist to testify about standards for managing a hair salon, a 13th District Texas Court of Appeals panel held May 26 in affirming a negligence verdict for a woman who had a severe reaction to hair dye (J.C. Penney Corp. v. Yolanda [...]